ArticleCEN case reports2024

Additional renoprotective effect of the SGLT2 inhibitor dapagliflozin in a patient with ADPKD receiving tolvaptan treatment.

Shun Minatoguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.